Amphastar Pharmaceuticals, Inc. - COM (AMPH)

Historical Portfolio Holders from Q2 2014 to Q1 2024

All holders as of March 31, 2024
Q1 2024
Type / Class
Equity / COM
Shares, excl. options Q1 2024
32.9 M
Holdings value Q1 2024
$1.44 B
Value change Q1 2024
+$2.58 M
Grand Portfolio weight change Q1 2024
+0%
Number of holders
259
Number of buys Q1 2024
128
Number of sells Q1 2024
-144
Average buys Q1 2024 %
+0.001%
Average sells Q1 2024 %
-0.001%
CUSIP
03209R103
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q1 32.9 M $1.44 B +$2.58 M $43.91 259
2023 Q4 32.3 M $2 B +$87.3 M $61.85 268
2023 Q3 31.9 M $1.47 B +$20.6 M $45.99 247
2023 Q2 31.3 M $1.8 B +$73.8 M $57.47 237
2023 Q1 30.1 M $1.13 B +$44.4 M $37.50 211
2022 Q4 29 M $813 M -$20.5 M $28.02 200
2022 Q3 28.7 M $807 M -$33 M $28.10 185
2022 Q2 30.2 M $1.05 B +$38.1 M $34.79 210
2022 Q1 29 M $1.04 B +$27.4 M $35.90 197
2021 Q4 29 M $674 M +$19.5 M $23.29 160
2021 Q3 27.9 M $530 M +$12.4 M $19.01 135
2021 Q2 27.1 M $547 M +$23.7 M $20.16 140
2021 Q1 26 M $476 M +$861 K $18.32 129
2020 Q4 25.9 M $521 M -$3.02 M $20.11 122
2020 Q3 26.1 M $490 M -$4.98 M $18.75 126
2020 Q2 26.3 M $591 M +$55.4 M $22.46 129
2020 Q1 23.8 M $353 M -$14 M $14.84 99
2019 Q4 24.5 M $473 M +$9.59 M $19.29 113
2019 Q3 24.1 M $477 M +$39.4 M $19.83 127
2019 Q2 22.3 M $470 M +$11 M $21.11 124
2019 Q1 22.2 M $454 M +$5.83 M $20.43 128
2018 Q4 22.1 M $440 M +$30.7 M $19.90 126
2018 Q3 20.6 M $397 M +$12 M $19.24 102
2018 Q2 20.1 M $307 M -$10 M $15.26 106
2018 Q1 20.5 M $384 M +$3.37 M $18.75 113
2017 Q4 20.5 M $395 M +$7.44 M $19.24 101
2017 Q3 20.2 M $362 M -$3.14 M $17.87 99
2017 Q2 20.4 M $365 M +$4.13 M $17.86 105
2017 Q1 20.4 M $296 M +$42.3 M $14.50 113
2016 Q4 22.3 M $411 M +$7.36 M $18.42 132
2016 Q3 22.2 M $421 M +$115 M $18.97 133
2016 Q2 16.2 M $261 M +$32.1 M $16.12 104
2016 Q1 14.3 M $171 M -$8.85 M $12.00 93
2015 Q4 14.7 M $210 M +$13 M $14.23 93
2015 Q3 12.1 M $141 M -$5.57 M $11.69 89
2015 Q2 13.2 M $232 M +$48.3 M $17.58 83
2015 Q1 10.6 M $158 M +$42.1 M $14.96 57
2014 Q4 7.79 M $90.4 M +$5.9 M $11.61 52
2014 Q3 7.24 M $84.4 M +$80.9 M $11.64 44
2014 Q2 300 K $3 M +$3 M $10.01 2